Home » Topics » BioWorld

BioWorld
RSS

HEMACARE AIDS THERAPY DESIGNATED ORPHAN

April 8, 1992

FDA APPROVES ABBOTT MONOCLONAL ASSAY

April 7, 1992

TRANSKARYOTIC LICENSES FACTOR IX

April 7, 1992

COLLABORATION TO BUILD ON CANCER DISCOVERY

April 7, 1992

GYNEX TO TEST OXANDRIN FOR AIDS PATIENTS

April 7, 1992

COMBINATION ARTHRITIS TREATMENT

April 7, 1992

HUMAN CLOTTING FACTOR FROM TRANSGENIC PIGS

April 7, 1992

ORGANOGENESIS FINDS PARTNER IN JAPAN

April 7, 1992

ENZO WINS PATENT CHALLENGE IN EUROPE

April 7, 1992

MERCK EXTENDS IMMULOGIC AGREEMENT

April 7, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...